Quick explanation behind the technology of India’s Covaxin:
As an inactivated vaccine, Covaxin uses a more traditional technology that is similar to the inactivated polio vaccine. Initially, a sample of SARS-CoV-2 was isolated by India’s National Institute of Virology and used to grow large quantities of the virus using vero cells.
From then on, the viruses are soaked in beta-propiolactone, which deactivates them by binding to their genes, while leaving other viral particles intact. The resulting inactivated viruses are then mixed with the aluminium-based adjuvant Alhydroxiquim-II.
The vaccine candidate is produced with Bharat Biotech’s in-house vero cell manufacturing platform that has the capacity to deliver about 300 million doses.
Ocugen has entered into a partnership with Bharat Biotech to co-develop and exclusively commercialise Covaxin in the US market
Thanks, Seek, this is good news.
For folks who want a vaxx, choice is good.
But I still think mass vaxxing for CoupFlu during the outbreak is nuts.